Product image of Levodopa Benserazid Beta (Benserazide, Levodopa) supplied by GNH India

Levodopa Benserazid Beta

Active Ingredient:
Benserazide, Levodopa
Origin:
EU

Levodopa Benserazid Beta (Benserazide, Levodopa)

Levodopa and Benserazide, the active ingredients in Levodopa Benserazid Beta, are a dopamine precursor and a dopa‑decarboxylase inhibitor presented as an oral tablet for oral use. They are used to increase central dopamine levels and alleviate motor symptoms in patients with Parkinson's disease and related Parkinsonian syndromes.

GNH India supplies Levodopa Benserazid Beta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets and providing reliable logistics for global distribution.

Manufacturer / TM Owner

Betapharm Arzneimittel Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levodopa/Benserazide is indicated for the management of Parkinsonian disorders, acting on the dopaminergic pathway to improve motor function.

  • Parkinson's disease: reduces bradykinesia, rigidity and tremor, improving daily activities.
  • Parkinsonian syndrome: alleviates motor symptoms associated with secondary Parkinsonism.
  • Off‑period symptoms in Parkinson's disease: smooths fluctuations in motor control during dosing intervals.

How It Works

  • Levodopa crosses the blood‑brain barrier and is decarboxylated to dopamine within central neurons, replenishing depleted dopamine stores. Benserazide, a peripheral dopa‑decarboxylase inhibitor, blocks conversion of levodopa outside the brain, thereby increasing the amount of levodopa that reaches the central nervous system and enhancing its therapeutic effect.

Side Effects

Levodopa/Benserazide may cause a range of adverse reactions.

Common Side Effects

  • Nausea: mild to moderate upset stomach.
  • Vomiting: occasional emesis after dosing.
  • Orthostatic hypotension: dizziness upon standing.
  • Dizziness: transient light‑headedness.
  • Dyskinesia: involuntary movements with higher doses.
  • Insomnia: difficulty sleeping.

Serious or Rare Side Effects

  • Severe hypotension: marked blood‑pressure drop requiring medical attention.
  • Neuroleptic malignant syndrome: life‑threatening reaction when combined with dopamine antagonists.
  • Cardiac arrhythmias: irregular heart rhythm in susceptible patients.
  • Hallucinations or psychosis: visual disturbances or delusional thoughts.
  • Severe allergic reactions: rash, swelling, or anaphylaxis.
  • Respiratory depression: rare but critical breathing difficulty.

Precautions & Warnings

Levodopa/Benserazide requires careful clinical monitoring.

  • Dose titration: start low and increase gradually to minimize dyskinesia.
  • Monitor for dyskinesia: adjust dose if involuntary movements appear.
  • Avoid high‑protein meals: protein can reduce levodopa absorption.
  • Caution in hepatic/renal impairment: dose may need adjustment.
  • Do not discontinue abruptly: taper under medical supervision.
  • Store below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Levodopa/Benserazide interacts with several medicines and substances.

Major Interactions (Avoid)

  • Non‑selective MAO inhibitors: risk of hypertensive crisis.
  • Antipsychotics (dopamine antagonists): may block therapeutic effect.
  • Pyridoxine (vitamin B6): enhances peripheral decarboxylation, reducing efficacy.
  • High‑protein meals: compete for transport, decreasing central availability.
  • Iron or antacids: may chelate levodopa, lowering absorption.

Moderate Interactions (Monitor Closely)

  • Antihypertensive agents: additive blood‑pressure lowering.
  • Selective MAO‑B inhibitors: may increase dopaminergic activity.
  • SSRIs or SNRIs: potential for serotonin syndrome.
  • Other dopaminergic drugs (e.g., bromocriptine): may increase dyskinesia risk.
  • Diuretics: may affect fluid balance and blood pressure.

Frequently Asked Questions

Levodopa Benserazid Beta is used to treat the motor symptoms of Parkinson's disease and related Parkinsonian syndromes. By increasing dopamine levels in the brain, it helps reduce stiffness, tremor, and slowness of movement, improving patients' ability to perform daily activities.

Levodopa is a precursor of dopamine that crosses the blood‑brain barrier. Once inside the central nervous system, it is converted to dopamine, replenishing the neurotransmitter that is deficient in Parkinson's disease. Benserazide blocks peripheral conversion, allowing more levodopa to reach the brain.

The exact dose is individualized and set by the prescribing clinician based on disease severity, patient response, and tolerance. Physicians typically start with a low dose and adjust gradually to achieve optimal symptom control while minimizing side effects.

Safety data for use in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levodopa combined with benserazide is considered the most effective symptomatic therapy for Parkinson's disease, especially in later stages. Dopamine agonists or MAO‑B inhibitors may be used earlier or as adjuncts, but they generally provide less robust motor improvement compared with levodopa/benserazide.

The product should be stored below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keeping the tablets in a dry, cool environment helps maintain their potency throughout the shelf life.

Levodopa Benserazid Beta is taken orally, usually with a small amount of water. It is often recommended to take the medication on an empty stomach, about 30 minutes before or one hour after meals, to improve absorption.

Serious risks include severe hypotension, neuroleptic malignant syndrome when combined with dopamine antagonists, cardiac arrhythmias, and psychotic reactions such as hallucinations. Patients should be monitored closely for these events, especially during dose adjustments.

Patients with known hypersensitivity to levodopa, benserazide, or any excipients should avoid the product. It is also contraindicated in individuals taking non‑selective MAO inhibitors or those with narrow‑angle glaucoma without specialist supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Benserazide, Levodopa

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT